Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

U.S. v. Sandoz (Generic Drug Antitrust Conspiracies)

The U.S. Department of Justice charged Novartis’ Sandoz unit with conspiring to allocate customers, rig bids, and fix prices for generic drugs. The charged conspiracies took place between 2013 and 2015. Sandoz admitted that it participated in the charged antitrust conspiracies with regard to the following drugs: clobetasol (cream, emollient cream, gel, ointment, and solution), desonide ointment, nystatin triamcinolone cream, benazepril HCTZ, and tobramycin inhalation solution. The company entered into a deferred prosecution agreement with the government and paid a $195 million criminal penalty to resolve the charges.

Misconduct Type
Antitrust
Enforcement Agency
Justice
Contracting Party
None
Court Type
Criminal
Disposition
Deferred Prosecution Agreement
Date of Deferred Prosecution Agreement
3/2/2020
Contractors Involved Penalty
Total
Novartis AG $195,000,000
Further Information Released
Criminal Information 3/2/2020
Deferred Prosecution Agreement 3/2/2020
DOJ Press Release 3/2/2020

See also:

Federal Contractor Misconduct Database